Krzysztof Dyrbuś

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 305 citations · Full text

Public Health, Endocrinology, Genetics +13

PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021

Maciej Banach, Paweł Burchardt, Krzysztof Chlebus et al. · Archives of Medical Science · 2021 · 154 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Usefulness of Atorvastatin in Patients With Heart Failure Due to Inflammatory Dilated Cardiomyopathy and Elevated Cholesterol Levels

Romuald Wojnicz, Krzysztof Wilczek, Ewa Nowalany-Kozielska et al. · The American Journal of Cardiology · 2006 · 103 citations

Medicine, Cardiology, Pharmacology +16

Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)

Maciej Banach, Peter E. Penson, Michal Vráblík et al. · Pharmacological Research · 2021 · 97 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease

Tadeusz Osadnik, Joanna Katarzyna Strzelczyk, Michał Hawranek et al. · BMC Cardiovascular Disorders · 2013 · 82 citations · Full text

Medicine, Biostatistics, Cardiology +16